Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Understand how income and capital gains from dividend ETFs differ and why tax efficiency matters. This intro explains the basic tradeoffs and what factors influence your after-tax results.
27,312 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
As AI reshapes software profits, select lightly priced players with durable moats and capable leadership attract barg...
Dell Technologies reports a surge in AI server demand that lifts revenue, yet gross margins slide as AI-related sales...
A major government contract marks a turning point for Palantir. This analysis explains how the DHS deal could reshape...
Eli Lilly kicked off 2026 with blockbuster sales and higher guidance, reigniting talk of a path to $1800 for Lilly st...
Marvell Technology extended a dramatic rally, up 45% in a month on record revenue, while investors weigh whether to t...
On March 2, Ondas surged on news of a $10 million strategic investment and a World View defense partnership. This art...
Micron Technology posted strong quarterly results amid a persistent memory-chip shortage that investors expect to end...
May 2026 hands investors a surprise: a big jump in M2 money supply could rekindle inflation pressures. Markets weigh ...
A broad selloff descends into rout in South Korea, sending the KOSPI to its worst daily decline in 16 years. Margin c...
Rising AI chip costs and surging demand threaten to reshape consumer budgets, credit behavior, and retirement plannin...
Micron Technology has logged an extraordinary 800% rally over the past year, but fresh analysis flags headwinds that ...